Skip to content

Clinical Efficacy Observation of a New Digital Electric Fire Needle Instrument in the Treatment of Upper Limb Spastic Hemiplegia after Stroke

Clinical Efficacy Observation of a New Digital Electric Fire Needle Instrument in the Treatment of Upper Limb Spastic Hemiplegia after Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000354
Enrollment
Unknown
Registered
2025-02-19
Start date
2025-03-16
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper limb spastic hemiplegia after stroke

Interventions

treatment group:active treatment

Sponsors

Beijing Huguosi Traditional Chinese Medicine Hospital affiliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Meeting the above diagnostic criteria of both traditional Chinese medicine and Western medicine; 2) Aged between 45 and 80 years old, regardless of gender; 3) Suffering from the first stroke, or having no history of spastic hemiplegia caused by previous strokes, and the current course of the disease is within 1 to 6 months; 4) When the affected upper limb is evaluated by the Modified Ashworth Scale (MAS), the MAS rating is = Grade 1 and = Grade 3; 5) Being conscious, having stable vital signs, and being able to cooperate in completing various scale assessments; 6) Having never experienced or received any form of fire needle treatment; 7) Having not used sedatives, muscle relaxants, or any drugs that affect muscle tone within the past two weeks; 8) The patient and their family members have been informed about the clinical trial, consent to participate in it, and voluntarily sign the informed consent form to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Pregnant women and women during the lactation period; 2) Patients complicated with severe infections or severe diseases of the liver heart kidneys and hematopoietic system; 3) Those with a history of upper limb spastic lesions caused by fractures tumors or other neuromuscular diseases; 4) Patients who resist acupuncture treatment or have contraindications to fire needle therapy (such as poor blood sugar control in diabetes anemia local infections ulcers etc.); 5) Those who cannot adhere to the treatment due to reasons such as financial difficulties or long distances.

Design outcomes

Primary

MeasureTime frame
modified Ashworth scale;

Secondary

MeasureTime frame
Hamilton Anxiety Rating Scale(HAMA);National Institutes of Health Stroke Scale(NIHSS);The Simplified Fugl-Meyer Assessment Scale (FMA);Modified Barthel Index;Visual Analogue Scale for Pain(VAS);

Countries

China

Contacts

Public ContactMeng Xiaonan Zhao Baixiao

Beijing Huguosi Traditional Chinese Medicine Hospital affiliated to Beijing University of Chinese Medicine

mengxiaonan.cn@gmail.com+8613810988685

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026